Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Maury Raycroft is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/17/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | TNGX | Buy Now | Tango Therapeutics | $9.46 | 100.85% | → $19 | Initiates | → Buy | Get Alert |
| 05/28/2024 | CALT | Buy Now | Calliditas Therapeutics | $38.56 | 1.14% | $58 → $39 | Downgrade | Buy → Hold | Get Alert |
| 05/07/2024 | PRME | Buy Now | Prime Medicine | $6.66 | 125.23% | $23 → $15 | Assumes | Buy → Buy | Get Alert |
| 03/22/2024 | DNTH | Buy Now | Dianthus Therapeutics | $28.50 | 36.84% | $22 → $39 | Maintains | Buy | Get Alert |
| 03/13/2024 | CUE | Buy Now | Cue Biopharma | $0.88 | 579.69% | → $6 | Initiates | → Buy | Get Alert |
| 03/06/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $60.28 | -23.69% | $4 → $46 | Upgrade | Hold → Buy | Get Alert |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $5.25 | 338.1% | → $23 | Initiates | → Buy | Get Alert |
| 02/08/2024 | TPST | Buy Now | Tempest Therapeutics | $2.15 | 596.06% | → $15 | Initiates | → Buy | Get Alert |
| 12/26/2023 | DNTH | Buy Now | Dianthus Therapeutics | $28.50 | -22.81% | → $22 | Initiates | → Buy | Get Alert |
| 10/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $55 → $58 | Downgrade | Buy → Hold | Get Alert |
| 08/04/2023 | BCRX | Buy Now | BioCryst Pharma | $7.45 | 47.65% | → $11 | Upgrade | Hold → Buy | Get Alert |
| 07/31/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $104 → $172.5 | Downgrade | Buy → Hold | Get Alert |
| 05/15/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | $3.5 → $1.5 | Downgrade | Buy → Hold | Get Alert |
| 05/12/2023 | ALLK | Buy Now | Allakos | $0.87 | 931.05% | $6 → $9 | Upgrade | Hold → Buy | Get Alert |
| 01/31/2023 | CMPX | Buy Now | Compass Therapeutics | $1.10 | 627.27% | → $8 | Initiates | → Buy | Get Alert |
| 01/04/2023 | VERA | Buy Now | Vera Therapeutics | $38.19 | -84.29% | $32 → $6 | Downgrade | Buy → Hold | Get Alert |
| 11/29/2022 | ARWR | Buy Now | Arrowhead Pharma | $29.02 | 158.44% | $92 → $75 | Maintains | Buy | Get Alert |
| 11/22/2022 | IMGO | Buy Now | Imago BioSciences | — | — | $35 → $36 | Downgrade | Buy → Hold | Get Alert |
| 10/03/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $242.99 | -4.52% | $218 → $232 | Maintains | Buy | Get Alert |
| 09/12/2022 | RZLT | Buy Now | Rezolute | $4.63 | 137.62% | → $11 | Initiates | → Buy | Get Alert |
| 09/02/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | $28 → $20 | Downgrade | Buy → Hold | Get Alert |
| 04/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $39 → $55 | Downgrade | Buy → Hold | Get Alert |
| 03/08/2022 | TYRA | Buy Now | Tyra Biosciences | $21.55 | 25.29% | $31 → $27 | Upgrade | Hold → Buy | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | $0.87 | — | — | Downgrade | Buy → Hold | Get Alert |
| 12/02/2021 | BYSI | Buy Now | BeyondSpring | $2.35 | 112.77% | — | Downgrade | Buy → Hold | Get Alert |
| 11/30/2021 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | — | Upgrade | Hold → Buy | Get Alert |
| 07/09/2021 | ASLN | Buy Now | ASLAN Pharma | $0.63 | 1169.84% | → $320 | Initiates | → Buy | Get Alert |
| 08/28/2018 | AFMD | Buy Now | Affimed | $5.56 | -28.06% | $18 → $40 | Upgrade | Hold → Buy | Get Alert |
| 05/19/2016 | AFMD | Buy Now | Affimed | $5.56 | -28.06% | $50 → $40 | Maintains | Hold | Get Alert |
| 10/15/2015 | AFMD | Buy Now | Affimed | $5.56 | 25.9% | $110 → $70 | Maintains | Hold | Get Alert |
| 09/09/2015 | AFMD | Buy Now | Affimed | $5.56 | 97.84% | → $110 | Initiates | → Hold | Get Alert |
| 06/22/2015 | AFMD | Buy Now | Affimed | $5.56 | 187.77% | $120 → $160 | Maintains | Buy | Get Alert |
